2.22
price up icon0.45%   0.01
after-market Handel nachbörslich: 2.21 -0.01 -0.45%
loading

Sab Biotherapeutics Inc Aktie (SABS) Neueste Nachrichten

pulisher
04:23 AM

Why SAB Biotherapeutics Inc. Equity Warrant stock attracts strong analyst attentionQuarterly Earnings Summary & Short-Term High Return Strategies - Newser

04:23 AM
pulisher
04:05 AM

Should you hold or exit SAB Biotherapeutics Inc. Equity Warrant nowTrend Reversal & AI Forecast Swing Trade Picks - Newser

04:05 AM
pulisher
03:54 AM

Can SAB Biotherapeutics Inc. hit a new high this monthJuly 2025 Earnings & Stepwise Swing Trade Plans - Newser

03:54 AM
pulisher
03:33 AM

Measuring SAB Biotherapeutics Inc.’s beta against major indicesInflation Watch & Real-Time Price Movement Reports - Newser

03:33 AM
pulisher
03:30 AM

SAB Biotherapeutics, Inc. (NASDAQ:SABS) Short Interest Up 3,433.6% in July - Defense World

03:30 AM
pulisher
02:05 AM

Brookline Capital Management Weighs in on SABS Q3 Earnings - Defense World

02:05 AM
pulisher
Aug 14, 2025

What recovery options are there for SAB Biotherapeutics Inc. Equity WarrantWeekly Loss Report & Technical Analysis for Trade Confirmation - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Chart based exit strategy for SAB Biotherapeutics Inc.2025 Macro Impact & AI Powered Market Trend Analysis - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Analyzing SAB Biotherapeutics Inc. with multi timeframe charts2025 Market Sentiment & Weekly Stock Breakout Alerts - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Price momentum metrics for SAB Biotherapeutics Inc. explainedMarket Performance Report & Fast Gain Swing Trade Alerts - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

What to do if you’re stuck in SAB Biotherapeutics Inc.July 2025 Retail & Reliable Price Breakout Alerts - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Key metrics from SAB Biotherapeutics Inc.’s quarterly dataTrade Ideas & Scalable Portfolio Growth Methods - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Why SAB Biotherapeutics Inc. stock attracts strong analyst attentionWeekly Stock Report & Fast Gaining Stock Reports - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

What MACD signals say about SAB Biotherapeutics Inc.Weekly Trade Review & High Win Rate Trade Alerts - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Will SAB Biotherapeutics Inc. stock benefit from interest rate changes2025 Market Outlook & Real-Time Market Trend Scan - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Can swing trading help recover from SAB Biotherapeutics Inc. Equity Warrant lossesProfit Target & AI Enhanced Trading Alerts - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

SAB Biotherapeutics Inc. Equity Warrant stock retracement – recovery analysis2025 Top Gainers & Risk Controlled Daily Trade Plans - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Advanced analytics toolkit walkthrough for SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Highlights & AI Forecast Swing Trade Picks - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Exit strategy if you’re trapped in SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Pullbacks & Low Drawdown Momentum Ideas - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

How hedge fund analytics apply to SAB Biotherapeutics Inc. Equity Warrant stock2025 Market WrapUp & Low Drawdown Investment Ideas - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

How hedge fund analytics apply to SAB Biotherapeutics Inc. Equity Warrant stock [2025 Breakouts & Breakdowns]AI Driven Stock Reports - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Top chart patterns to watch in SAB Biotherapeutics Inc.Short-Term Sector Movement Forecast Generator - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Applying Elliott Wave Theory to SAB Biotherapeutics Inc. Equity WarrantPredictive AI Engine for Smart Investing - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

How SAB Biotherapeutics Inc. Equity Warrant stock performs during market volatilityChart Based Entry Tool for ROI Traders - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

SAB Biotherapeutics Inc. stock chart pattern explainedFree Pattern Detection for Entry Confirmation - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Can a trend reversal in SAB Biotherapeutics Inc. Equity Warrant lead to recoveryPredictive Screener for Daily Trade Watch - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

SAB Biotherapeutics Receives Buy Rating and $5.00 Price Target from Craig-Hallum - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Technical analysis overview for SAB Biotherapeutics Inc. stockRisk Shielded Trade Watch with Analysis - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Will SAB Biotherapeutics Inc. Equity Warrant continue its uptrendFree Short Term Buy List With Stop Protection - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Predicting SAB Biotherapeutics Inc. Equity Warrant trend using moving averagesSafe Investment Ideas with Growth Upside - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Analyzing net buyer seller activity in SAB Biotherapeutics Inc.Free Trade Setups With Clear Risk Limits - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Sector ETF performance correlation with SAB Biotherapeutics Inc. Equity WarrantTrading Opportunities Forecast by AI Insight - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Risk adjusted return profile for SAB Biotherapeutics Inc. Equity Warrant analyzedFree Trade Timing Strategy With Technical Data - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Ichimoku Cloud Indicates Uncertainty Around SAB Biotherapeutics Inc.Consistent Income Focused Trade List Analyzed - metal.it

Aug 10, 2025
pulisher
Aug 10, 2025

What makes SAB Biotherapeutics Inc. Equity Warrant stock price move sharplyAI-Based Reversal Point Prediction Signal - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

SAB Biotherapeutics Inc. stock volume spike explainedMinimal Risk Growth Investment Opportunity Analysis - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Chardan Capital Issues Pessimistic Forecast for SAB Biotherapeutics (NASDAQ:SABS) Stock Price - Defense World

Aug 10, 2025
pulisher
Aug 09, 2025

SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

What the charts say about SAB Biotherapeutics Inc. todayValue Holding Return Summary With Outlook - Newser

Aug 09, 2025
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Kapitalisierung:     |  Volumen (24h):